key: cord-0720376-4do0kf5e authors: Kalia, Vandana; Studzinski, George P.; Sarkar, Surojit title: Role of vitamin D in regulating COVID‐19 severity—An immunological perspective date: 2021-01-19 journal: J Leukoc Biol DOI: 10.1002/jlb.4covr1020-698r sha: 30c5b28f7b146fb5160be61209fe32aa49eb841b doc_id: 720376 cord_uid: 4do0kf5e Vitamin D, a key nutrient/prohormone classically associated with skeletal health, is also an important immunomodulator, with pleotropic effects on innate and adaptive immune cells. Outcomes of several chronic, autoimmune, and infectious diseases are linked to vitamin D. Emergent correlations of vitamin D insufficiency with coronavirus‐induced disease 2019 (COVID‐19) severity, alongside empirical and clinical evidence of immunoregulation by vitamin D in other pulmonary diseases, have prompted proposals of vitamin D supplementation to curb the COVID‐19 public health toll. In this review paper, we engage an immunological lens to discuss potential mechanisms by which vitamin D signals might regulate respiratory disease severity in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) infections, vis a vis other pulmonary infections. It is proposed that vitamin D signals temper lung inflammatory cascades during SARS‐CoV2 infection, and insufficiency of vitamin D causes increased inflammatory cytokine storm, thus leading to exacerbated respiratory disease. Additionally, analogous to studies of reduced cancer incidence, the dosage of vitamin D compounds administered to patients near the upper limit of safety may serve to maximize immune health benefits and mitigate inflammation and disease severity in SARS‐CoV2 infections. We further deliberate on the importance of statistically powered clinical correlative and interventional studies, and the need for in‐depth basic research into vitamin D‐dependent host determinants of respiratory disease severity. Vitamin D 3 (cholecalciferol) is produced in the skin from 7dehydrocholesterol through a 2-step process by UVB radiation from the sun, to first form pre-D 3 , which then isomerizes to vitamin D 3 in a nonenzymatic process. The rate of vitamin D 3 production in the skin is regulated by multiple factors, such as melanin pigmentation level and UVB intensity (as determined by seasonal angle of the sun, latitude, clothing, and sunscreen usage). Vitamin D may also be pro- for skeletal health. 9 However, it has been shown in numerous studies that higher 25-hydroxyvitamin D serum concentrations are associated with a reduction of diseases other than rickets and osteomalacia, for instance, a lower cancer incidence and cancer mortality. 10 In general, age, certain genetic or ethnic backgrounds, and preexistent chronic disease conditions are linked to disproportionately exacerbated respiratory disease severity in COVID-19. 13 64 Other innate cells such as neutrophils are also functionally activated by vitamin D signals. 65 ligands, 112 and also suppresses pathogenic B cell responses. 60, 61, 72 In the case of HSV-induced Behcet's inflammatory disease, vitamin D mediates protective, anti-inflammatory effects through downregulation of TLRs. 113, 114 Anti-inflammatory effects of vitamin D are also implicated in successful organ transplantation. 73, [115] [116] [117] [118] In endotoxin-induced acute respiratory distress syndrome (ARDS), inadequate vitamin D level is associated with increased levels of inflammatory cytokines such as IL-1 and TNF-. 119 Strong host inflammation is a lead cause of exacerbated lung disease in TB and influenza. 123, 124 Although rapid induction of proinflammatory cytokines and chemokines is a key part of early immune anti-viral defense, and is also critical for recruitment of additional innate cells (such as monocytes and NK cells) as well as adaptive immune cells to sites of viral replication in the lung, overexuberant and/or prolonged inflammation in the lung causes significant lung damage, ARDS and mortality. 111 In the highly pathogenic 1918 Influenza A, pulmonary pathology and fatal outcome were associated with accelerated activation of proinflammatory genes that remained unabated until death. [125] [126] [127] [128] Hence, therapies aimed at reducing the cytokine storm are proposed to be beneficial for severe cases of influenza. 129 As in pathogenic influenza, SARS-CoV2 infection in humans is associated with replication of the virus in the lower respiratory tract, which is accompanied by severe inflammation owing to increased localization of inflammatory macrophages to lung airways. 13, 123, 125, [130] [131] [132] [133] [134] [135] Profound impact of vitamin D on immunity to a variety of respiratory/mucosal diseases characterized by inflammation (influenza, TB, MS) 13, 42, 44, 125 supports vitamin D-dependent regulation of innate and adaptive inflammatory mediators/regulators of pulmonary immunopathology and ARDS during COVID-19 as well (Fig. 1) . Increased inflammation is implicated as the prime cause for morbidity/mortality in vulnerable patients, with more severe COVID-19 cases associated with greater inflammatory cytokine induction and vitamin D insufficiency. [14] [15] [16] 125, 130, [134] [135] [136] [137] [138] The adaptive immune components, CD8 and CD4 T cells might also serve to exacerbate inflammation at lung sites as "latecomer" inflammatory mediators attracted by the initial innate chemoattractants at lung sites (Fig. 1) According to the National Health and Nutrition Examination Survey Table 1 ). Furthermore, Dr. Niels Finsen's Nobel Prize winning cure of epidermal TB through sunlight lends historic support. 152 Metadata analysis of studies involving a large cohort of participants (>11,000) also promisingly found a protective effect of higher vitamin D levels in acute respiratory infections 153 (Table 1) . Even in bacterial sepsis, AIDS, and parasitic infections, meta data analysis of controlled human trials have shown improved clinical outcomes following supplementation (Table 1) . 29 28, 30, 58, 112 (Table 1 ). It is predicted that augmenting the overall vitamin D levels in the population to "sufficient" levels will mitigate disease severity in the general population, and will be especially is expected to induce optimal activation of innate immune cells such as macrophages (with robust antimicrobial peptide, AMP, production) and DCs with robust up-regulation of MHC and costimulatory molecules, and regulated production of proinflammatory cytokines. Balanced differentiation of effector CD8 and CD4 T cell subsets under conditions of vitamin D sufficiency is also expected to promote robust antiviral responses, with regulated production of inflammatory cytokines. Vitamin D sufficiency is also predicted to promote the development of immunoprotective NK-T cells, and maintain epithelial junctional integrity and endothelial vascular permeability, thus minimizing pulmonary damage. Contrarily, host vitamin D insufficiency or deficiency (red half of the figure, corresponding to serum levels of 25(OH)D ≤ 10 ng/ml (25 nM) defined as deficient, and 10-20 ng/ml defined as insufficient) is expected to lead to aberrant activation of innate inflammatory mediators such as macrophages and DCs, leading to exacerbated inflammation, more pronounced expansion and terminal differentiation of effector CD8 and inflammatory CD4 T cell subsets, and diminished Treg induction and NK-T cell development. Likewise, the junctional integrity of lung epithelial and vascular endothelial cells is also predicted to be impaired, thus leading to pulmonary edema, lung injury and functional impairment and ARDS. Conditions of vitamin D hyper-supplementation are not depicted in this model. A better understanding of disease-context-dependent immunomodulatory effects of vitamin D in SARS-CoV2 infections at pulmonary sites of viral growth and secondary lymphoid sites of immune activation will illuminate potential beneficial effects of normalizing vitamin D levels to sufficient or hyper-supplemented levels Tuberculosis Martineau et al. 153 Nursyam et al. 175 Morcos et al. 176 Wejse 180 Leaf et al. 181 Quraishi et al. 182 Miroliaee et al. 183, 184 Ginde et al. 151 Coronary disease Sokol et al. 185 Farrokhian et al. 186 Bahrami et al. 187, 188 Manson et al. 28 Diabetes Pittas et al. 30 Multiple sclerosis Kouchaki et al. 34 Berezowska et al. 35 Dengue Ahmed et al. 32 Martinez-Moreno et al. 33 Selected The authors declare no conflicts of interest. https://orcid.org/0000-0003-1940-1878 SARS-CoV-2 (COVID-19) by the numbers Hospitalization and mortality among black patients and white patients with Covid-19 Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Why African Americans are a potential target for COVID-19 infection in the United States (USA) Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer Vitamin D control of hematopoietic cell differentiation and leukemia Vitamin D metabolism, mechanism of action, and clinical applications Vitamin D: beyond bone Consensus statement from 2(nd) International Conference on Controversies in Vitamin D 25-Hydroxyvitamin D and total cancer incidence and mortality: a meta-analysis of prospective cohort studies The mechanisms of vitamin D toxicity Hypervitaminosis D associated with drinking milk Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality Does vitamin D status impact mortality from SARS-CoV-2 infection Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity Vitamin D: modulator of the immune system Low bone mineral content in summer-born compared with winter-born infants Low bone mineral content and high serum osteocalcin and 1,25-dihydroxyvitamin D in summer-versus winter-born newborn infants: an early fetal effect Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline Sub-continental atmosphere and inherent immune system may have impact on novel corona virus' 2019 (nCovid-19) prevalence in South East Asia 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2 A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency Low plasma levels of cholecalciferol and 13-cis-retinoic acid in tuberculosis: implications in hostbased chemotherapy Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy Vitamin D supplements and prevention of cancer and cardiovascular disease The potential protective role of vitamin D supplementation on HIV-1 infection Vitamin D supplementation and prevention of type 2 diabetes Effect of vitamin D3 supplementation on HIV-infected adults: a systematic review Micronutrients and dengue Effect of high doses of vitamin D supplementation on dengue virus replication, Tolllike receptor expression, and cytokine profiles on dendritic cells High-dose omega-3 fatty acid plus vitamin D3 supplementation affects clinical symptoms and metabolic status of patients with multiple sclerosis: a randomized controlled clinical trial Effectiveness of vitamin D supplementation in the management of multiple sclerosis: a systematic review Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling Murine CD8+ T cells but not macrophages express the vitamin D 1alpha-hydroxylase Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses Serum 25-hydroxyvitamin D and colon cancer: eightyear prospective study Vitamin d and its role in cancer and immunity: a prescription for sunlight The role of vitamin D3 in preventing infections Epidemic influenza and vitamin D Re: epidemic influenza and vitamin D Pandemic influenza A (H1N1): mandatory vitamin D supplementation Vitamin D deficiency and hepatitis viruses-associated liver diseases: a literature review Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Vitamin d, vitamin d receptor, and cathelicidin in the treatment of tuberculosis Mycobacterium bovis infection of vitamin D-deficient NOS2-/-mice Elevated non-specific immunity and normal Listeria clearance in young and old vitamin D receptor knockout mice 1,25-dihydroxyvitamin D3 receptors in human leukocytes Vitamin D and immune function: understanding common pathways 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3 Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system DCs metabolize sunlightinduced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells Vitamin D in systemic and organ-specific autoimmune diseases One calcitriol dose transiently increases Helios+ FoxP3+ T cells and ameliorates autoimmune demyelinating disease High-dose cholecalciferol supplementation significantly increases peripheral CD4 Tregs in healthy adults without negatively affecting the frequency of other immune cells Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response 25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway Regulation of immune function by vitamin d and its use in diseases of immunity Immunomodulation by vitamin D: implications for TB Vitamin D-cathelicidin axis: at the crossroads between protective immunity and pathological inflammation during infection Vitamin D is required for IFNgamma-mediated antimicrobial activity of human macrophages Vitamin D controls T cell antigen receptor signaling and activation of human T cells Why do T cells express the vitamin D receptor Vitamin D receptor signals regulate effector and memory CD8 T cell responses to infections in mice Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice The vitamin D receptor is required for iNKT cell development 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3 Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes OH)2D3 induces regulatory T cell differentiation by influencing the VDR/PLC-gamma1/TGF-beta1/pathway CD8 T cell memory to pathogens. Encyclopedia of Immunobiology Quiescence of memory CD8(+) T cells is mediated by regulatory t cells through inhibitory receptor CTLA-4 Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3 Regulatory T cells in virus infections Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection Regulatory T cells: mechanisms of differentiation and function Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation Effects of 1alpha,25(OH)2D3 and its analogs on dendritic cell function Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis Vitamin D and its analogs as regulators of immune activation and antigen presentation 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes 25-dihydroxyvitamin D3 inhibits CD40L-induced proinflammatory and immunomodulatory activity in human monocytes Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory Linking vitamin d deficiency to inflammatory bowel disease Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis 1,25-Dihydroxyvitamin D protects intestinal epithelial barrier by regulating the myosin light chain kinase signaling pathway Vitamin D and innate and adaptive immunity Vitamin D and immune function: an overview Regulation of IL-1 family cytokines IL-1alpha, IL-1 receptor antagonist, and IL-18 by 1,25-dihydroxyvitamin D3 in primary keratinocytes Modulation of the immune response to respiratory viruses by vitamin D 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization The effect of 25(OH)D on endothelial and immunological markers in Behcet's disease Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease The role of vitamin D and omega-3 PUFAs in islet transplantation Vitamin D deficiency in solid-organ transplant recipients from a Spanish Mediterranean population Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study Vitamin D and the risk of acute allograft rejection following human liver transplantation MicroRNA-mediated mechanism of vitamin D regulation of innate immune response 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages Dietary vitamin D3 deficiency increases resistance to Leishmania (Leishmania) amazonensis infection in mice Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major The host immune response in respiratory virus infection: balancing virus clearance and immunopathology The dual role of innate immunity during influenza The trinity of COVID-19: immunity, inflammation and intervention H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus The pathogenesis and treatment of thè Cytokine Storm' in COVID-19 The many faces of the anti-COVID immune response Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions COVID-19: immunology and treatment options COVID-19: immunopathology and its implications for therapy The amount of cytokinerelease defines different shades of Sars-Cov2 infection Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients Greiffenstein P. Vitamin D insufficiency is prevalent in severe COVID-19. medRxiv Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics Type I IFN immunoprofiling in COVID-19 patients Type I and III interferons disrupt lung epithelial repair during recovery from viral infection Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target -a perspective. Endocr Metab Immune Disord Drug Targets Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Type III interferons disrupt the lung epithelial barrier upon viral recognition Imbalanced host response to SARS-CoV-2 drives development of COVID-19 Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes Vitamin D status in the United States Vitamin D deficiency in Europe: pandemic? Tackling inadequate vitamin D intakes within the population: fortification of dairy products with vitamin D may not be enough Demographic differences and trends of vitamin D insufficiency in the US population Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey The first Nobel Prize for medicine to the Nordic countries (Niels Ryberg Finsen 1903) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data Vitamin D as adjunctive therapy in refractory pulmonary tuberculosis: a case report Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers Vitamin D supplementation modulates T cell-mediated immunity in humans: results from a randomized control trial Daily cholecalciferol supplementation during pregnancy alters markers of regulatory immunity, inflammation, and clinical outcomes in a randomized controlled trial Machine learning approaches infer vitamin D signaling: critical impact of vitamin D receptor binding within topologically associated domains In vivo transcriptome changes of human white blood cells in response to vitamin D Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF Selective regulation of biological processes by vitamin D based on the spatio-temporal cistrome of its receptor Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genomewide shift in the locations of VDR chromatin occupancy Primary vitamin D target genes of human monocytes Cell entry mechanisms of SARS-CoV-2 The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice Tie-2Cre mediated deletion of the vitamin D receptor gene leads to improved skeletal muscle insulin sensitivity and glucose tolerance The vitamin D sytem in humans and mice: similar but not the same. Reports -Medical Cases, Images, and Video Role of vitamin D on gut microbiota in cystic fibrosis Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion Vitamin D administration to tuberculous children and its value Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis Short-term effects of highdose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study Randomized controlled trial of calcitriol in severe sepsis Effect of cholecalciferol supplementation on vitamin d status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial Effect of vitamin D supplementation on procalcitonin as prognostic biomarker in patients with ventilator associated pneumonia complicated with vitamin D deficiency The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease Long-term vitamin D supplementation affects metabolic status in vitamin D-deficient type 2 diabetic patients with coronary artery disease Vitamin D supplementation and serum heat shock protein 60 levels in patients with coronary heart disease: a randomized clinical trial Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis Role of vitamin D in regulating COVID-19 severity -An immunological perspective